Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gui-Shuang Ying

Showing results (1-10 of 503) with videos related to

Pageof 51
Sort By:
Investigative Ophthalmology & Visual Science|July 5, 2012
Is drusen area really so important?Gui-shuang Ying
Ophthalmic Epidemiology|October 27, 2025
The Global Burden of Blindness and Visual Impairment: Progress and ChallengesGui-Shuang Ying
JAMA Ophthalmology|November 8, 2019
A Prediction Model for Retinopathy of Prematurity-Is It Ready for Prime Time?Gui-Shuang Ying
JAMA Ophthalmology|May 3, 2019
Statistical Issues on Evaluating Association Between the Cilioretinal Artery and Age-Related Macular DegenerationGui-Shuang Ying
JAMA Ophthalmology|April 24, 2020
Inquiries on the Validation of a Model to Reduce Retinopathy of Prematurity Testing-ReplyGil Binenbaum, Gui-Shuang Ying
BMC Ophthalmology|October 1, 2025
A systematic review of the study design and statistical practices in randomized controlled trials on myopia treatment (2019-2023)Youvin Chung, Gui-Shuang Ying
Ophthalmology Science|February 17, 2023
Characteristics of Design and Analysis of Ophthalmic Randomized Controlled Trials: A Review of Ophthalmic Papers 2020-2021Ruiqi Dong, Gui-Shuang Ying
JAMA Ophthalmology|December 16, 2017
Role of Maternal Race on Algorithms Predicting Retinopathy of Prematurity-ReplyGil Binenbaum, Gui-Shuang Ying
Ophthalmic Research|July 30, 2020
Growth Rate of Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Meta-Analysis of Natural History Studies and Implications for Designing Future TrialsJianyong Wang, Gui-Shuang Ying
Clinical Trials (London, England)|January 17, 2013
Prediction of event times in the REMATCH TrialGui-Shuang Ying, Daniel F Heitjan
Pageof 51

Showing results (1-10 of 503) with videos related to

Sort By:
Pageof 51
Investigative Ophthalmology & Visual Science|July 5, 2012
Is drusen area really so important?Gui-shuang Ying
Ophthalmic Epidemiology|October 27, 2025
The Global Burden of Blindness and Visual Impairment: Progress and ChallengesGui-Shuang Ying
JAMA Ophthalmology|November 8, 2019
A Prediction Model for Retinopathy of Prematurity-Is It Ready for Prime Time?Gui-Shuang Ying
JAMA Ophthalmology|May 3, 2019
Statistical Issues on Evaluating Association Between the Cilioretinal Artery and Age-Related Macular DegenerationGui-Shuang Ying
JAMA Ophthalmology|April 24, 2020
Inquiries on the Validation of a Model to Reduce Retinopathy of Prematurity Testing-ReplyGil Binenbaum, Gui-Shuang Ying
BMC Ophthalmology|October 1, 2025
A systematic review of the study design and statistical practices in randomized controlled trials on myopia treatment (2019-2023)Youvin Chung, Gui-Shuang Ying
Ophthalmology Science|February 17, 2023
Characteristics of Design and Analysis of Ophthalmic Randomized Controlled Trials: A Review of Ophthalmic Papers 2020-2021Ruiqi Dong, Gui-Shuang Ying
JAMA Ophthalmology|December 16, 2017
Role of Maternal Race on Algorithms Predicting Retinopathy of Prematurity-ReplyGil Binenbaum, Gui-Shuang Ying
Ophthalmic Research|July 30, 2020
Growth Rate of Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Meta-Analysis of Natural History Studies and Implications for Designing Future TrialsJianyong Wang, Gui-Shuang Ying
Clinical Trials (London, England)|January 17, 2013
Prediction of event times in the REMATCH TrialGui-Shuang Ying, Daniel F Heitjan
Pageof 51